Business
HARMONY BIOSCIENCES TO PARTICIPATE IN 21st ANNUAL NEEDHAM VIRTUAL HEALTHCARE CONFERENCE
PLYMOUTH MEETING, Pa., April 4, 2022 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (Nasdaq: HRMY), a pharmaceutical company
About this update from Harmony Biosciences Holdings, Inc.
[{"type":"text","content":"PLYMOUTH MEETING, Pa., April 4, 2022 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. (\"Harmony\" or the \"Company\") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases, today announced that Harmony's President and CEO, John C. Jacobs, will present a company update and host investor meetings at the upcoming 21st Annual Needham Virtual Healthcare Conference.\n\n \n \n \n \n \n \n\n \n21st Annual Needham Virtual Healthcare ConferenceFireside Chat: Monday, April 11; 12:45 p.m.-1:25 p.m. ET1x1 Meetings: Monday, April 11A webcast of the fireside chat will be available on the investor page of Harmony's website at https://ir.harmonybiosciences.com/.\nAbout Harmony BiosciencesHarmony Biosciences is a commercial stage pharmaceutical company headquartered in Plymouth Meeting, PA. The Company was established by Paragon Biosciences, LLC, and is focused on providing novel treatment options for people living with rare neurological disorders who have unmet medical needs. For more information on Harmony, please visit the company's website: www.harmonybiosciences.com.\nHarmony Biosciences Investor Contact:Patti BankICR [email protected] \nHarmony Biosciences Media Contact:Nancy [email protected]\n\n\n\n View original content to download multimedia:https://www.prnewswire.com/news-releases/harmony-biosciences-to-participate-in-21st-annual-needham-virtual-healthcare-conference-301515924.html\nSOURCE Harmony Biosciences","length":3710,"tagName":"div"}]